Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4% year on year to $995.2 million. On the other hand, next quarter’s revenue guidance of $975 million was less impressive, coming in 5.5% below analysts’ estimates. Its non-GAAP profit of $2.44 per share was in line with analysts’ consensus estimates.
Metal packaging products manufacturer Crown Holdings (NYSE:CCK) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 1.6% year on year to $2.90 billion. Its non-GAAP profit of $1.59 per share was 5.3% above analysts’ consensus estimates.
Pet products provider Bark (NYSE:BARK) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 1.1% year on year to $126.4 million. On the other hand, next quarter’s revenue guidance of $126.2 million was less impressive, coming in 1.9% below analysts’ estimates. Its non-GAAP loss of $0.02 per share was in line with analysts’ consensus estimates.
Healthcare insurance company Molina Healthcare (NYSE:MOH) announced better-than-expected revenue in Q4 CY2024, with sales up 16% year on year to $10.5 billion. The company’s full-year revenue guidance of $44 billion at the midpoint came in 1.4% above analysts’ estimates. Its GAAP profit of $4.44 per share was 19% below analysts’ consensus estimates.
US stocks were higher amid a backdrop of scattered earnings and the outbreak of a trade war with China.
RFID manufacturer Impinj (NASDAQ:PI) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 29.6% year on year to $91.57 million. Next quarter’s revenue guidance of $71.5 million underwhelmed, coming in 22.8% below analysts’ estimates. Its non-GAAP profit of $0.48 per share was in line with analysts’ consensus estimates.
Cybersecurity software maker Tenable (NASDAQ:TENB) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 10.5% year on year to $235.7 million. On the other hand, next quarter’s revenue guidance of $233 million was less impressive, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.41 per share was 19% above analysts’ consensus estimates.
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue guidance of $1.36 billion at the midpoint came in 2.7% below analysts’ estimates. Its non-GAAP profit of $1.34 per share was 11.4% above analysts’ consensus estimates.
Semiconductor production equipment provider Amtech Systems (NASDAQ:ASYS) announced better-than-expected revenue in Q4 CY2024, but sales fell by 2.1% year on year to $24.39 million. On the other hand, next quarter’s revenue guidance of $22 million was less impressive, coming in 14.1% below analysts’ estimates. Its non-GAAP profit of $0.02 per share was significantly above analysts’ consensus estimates.
Wireless chipmaker Qualcomm (NASDAQ:QCOM) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 17.5% year on year to $11.67 billion. On top of that, next quarter’s revenue guidance ($10.75 billion at the midpoint) was surprisingly good and 4.2% above what analysts were expecting. Its non-GAAP profit of $3.41 per share was 14.9% above analysts’ consensus estimates.